Atlas Trials

Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)

Clinical trial NCT06127225 · COMPLETED

Trial details

NCT number
NCT06127225
Sponsor
Dexa Medica Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Alcoholic Fatty Liver Disease (NAFLD)
Start date
2023-04-28
Primary completion
2024-08-09
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.